The allegations in the case, N.F. v. Janssen Pharmaceuticals,
are that a young man taking Risperdal grew excessive breast tissue, a condition known as gynecomastia. According to court documents, the plaintiff had been diagnosed with Asperger's syndrome, impulse control disorder and oppositional defiance disorder. At the age of seven he was prescribed Risperdal, for the first time, and stayed on the antipsychotic for just over a year. A few years later he was placed on a generic form of the drug and remained on it for nearly four years.
READ MORE Risperday LEGAL NEWS
Risperdal is an atypical antipsychotic that works by changing the activity of certain natural substances in the brain. Developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, Risperdal was approved by the FDA in 1993 for the treatment of schizophrenia in adults. Risperdal Lawsuits have shown a link between Risperdal and growing male breasts, known as Risperdal gynecomastia. Other Risperdal side effects include tardive dyskinesia, high blood sugar and diabetes, stroke, heart attack and even death.